UTEXAS PARTNERS WITH TRIPLEBLIND
Preventing Hepatocellular Carcinoma (HCC) with Privacy-Centric Data Collaboration
In 2023, The Cancer Prevention and Research Institute of Texas (CPRIT) generously granted $90 million to fund programs to address the need for better public health monitoring of Hepatitis C patients in low-income South Texas communities. As a part of this grant, The University of Texas and TripleBlind partnered to uphold patient privacy, facilitate collaborative research, and improve the quality of patient care. Keep reading to learn how we’re working together to prevent cancer in Hepatitis C patients through privacy-centric collaboration.
“It’s a classic Catch-22: Patient privacy is of the utmost importance, but data sharing is critical because researchers use and analyze data to improve patient health.”
Hepatitis C, a condition that is increasing in younger populations, is a cause of Hepatocellular carcinoma (HCC) liver cancer.
Hepatitis C is a treatable condition but current technologies such as electronic medical recordings (EMRs), have limited reporting, tracking, and analysis capabilities, impeding efforts to improve outcomes.
“We are thrilled to work with TripleBlind to study the potential impact of software in accelerating evidence-based quality improvement, thereby addressing the needs of minority, low income populations who have a disproportionate need for better Hepatitis C screening, diagnosis, and treatment.”
Using TripleBlind’s proprietary automated de-identification and privacy enhancing software, the University of Texas will study the impact of these technologies on monitoring quality of care delivery across multiple federally qualified health centers (FQHCs).
This research will demonstrate the impact of using TripleBlind as a software solution, allowing institutions to perform collaborative research and improve quality of care via more direct data interactions between collaborating entities.
“Our technology makes it possible to maintain privacy and HIPAA compliance while also using data to improve health outcomes, such as in cancer care, particularly amongst the most socioeconomically disadvantaged populations. We believe this is critical to the future of healthcare globally. We’re excited and honored to participate in this research grant with Mamta Jain, Penny Flores, and the entire University of Texas team.”